- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak launches networking products
The Society for Computer Applications in Radiology meeting May 20 to 23 in Vancouver, BC, played host to the launch of several new Kodak image management technologies. Among them were archiving software, a Web-based service that remotely monitors
The Society for Computer Applications in Radiology meeting May 20 to 23 in Vancouver, BC, played host to the launch of several new Kodak image management technologies. Among them were archiving software, a Web-based service that remotely monitors installed digital imaging equipment, and secure e-mail services. Kodak's VIParchive software, which works with the company's DirectView PACS System 5, centrally manages images and patient information, as well as back office data including purchasing, inventory, and other records systems. The company's Remote Management Services package provides proactive system monitoring, remote diagnosis, and software distribution using secure, encrypted communications. It is designed to uncover and help repair errors before they cause equipment malfunctions. Secure Email Services enables any type of electronic document, including laboratory and radiology reports, electronic patient records, billing statements, and imaging studies to be sent securely over the Internet to physicians, patients, and healthcare providers in other countries.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
